Becton, Dickinson and Company: Diabetes Mellitus trials

The registry lists 10 Diabetes Mellitus studies with Becton, Dickinson and Company as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 2Phase 2 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Role of Proper Insulin Injection Technique in the Treatment of Diabetes MellitusCompletedNCT04120974Not applicableResults posted
• Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 DiabetesTerminatedNCT04090242Not applicableResults posted
• Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen NeedlesCompletedNCT01231984Not applicableResults posted
• Comparison of Glycemic Control Among Diabetics Using Three Different Pen NeedlesCompletedNCT00928057Not applicableResults posted
• Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood GlucoseCompletedNCT00741390Not applicableResults posted
• An Audit of the Impact of Tailored Information Delivered Via a Digital Learning PlatformTerminatedNCT04007003Not applicable
• Clinical Evaluation of BD NEXT Pen NeedleCompletedNCT01852136
• Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 DiabeticsCompletedNCT01645696Not applicable
• Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic PatientsCompletedNCT01120444Phase 1/2
• Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or SubcutaneouslyCompletedNCT01061216Phase 1/2